Stroke Survivors May Have Increased Risk of Cancer
NASHVILLE—The annual rate of age-adjusted cancer incidence is higher among patients who have had ischemic stroke,... More
Patients With Wake-Up Stroke May Be Candidates for t-PA
NASHVILLE—Tissue plasminogen activator (t-PA) appears to be safe in the treatment of stroke detected when people wake... More
DBS May Improve Impulse Control in Patients With Parkinson’s Disease
LAS VEGAS—Dopamine agonists can reduce the tremor, stiffness, and slowness associated with Parkinson’s disease, but... More
AAN and AHS Update Guideline for the Treatment of Acute Migraine
The American Headache Society (AHS), working in cooperation with the American Academy of Neurology (AAN), has provided... More
How Well Do Neurologists Understand Pediatric Stroke?
COLUMBUS, OHIO—Although investigators have studied stroke in adults for years, research into pediatric stroke is in its... More
Cognitive decline in middle age may not result from β-amyloid deposition, according to a study published online ahead of print March 16 in JAMA Neurology. Declines in memory and hippocampal volume occur at earlier ages than abnormal amyloid PET does... More »
 
Cerebral blood flow recovery could be a biomarker of outcomes in athletes following concussion, according to an imaging study published online ahead of print March 2 in JAMA Neurology. “To our knowledge, this study provides the first prospective ev... More »
 
Researchers have identified a genetic variation that significantly increases women’s risk of developing multiple sclerosis (MS). The variant, a single nucleotide polymorphism (SNP) in the gene serine-threonine-kinase 11 (STK11), occurs approximatel... More »
 
Among patients with Parkinson’s disease, probable REM sleep behavior disorder (RBD) is associated with longer disease duration and more severe symptoms, according to research published March 3 in Neurology. In addition, patients with Parkinson’s ... More »
 

International Stroke Conference

NASHVILLE—A low level of vitamin D independently predicts a large infarct volume and a poor outcome after ischemic stroke, according to a study described at the 2015 International Stroke Conference. “Though causality remains to be proven, our res... More »
 
Gout is inversely associated with the risk of developing Alzheimer’s disease, and uric acid may play a neuroprotective role, according to a study published March 4 in Annals of the Rheumatic Diseases. Researchers conducted a study using data from t... More »
 
Is Cannabis the New Frontier of Therapeutics? Humans have been using cannabis to relieve pain for about 5,000 years, but robust, federally approved research on marijuana’s therapeutic value is just starting to emerge. Researchers who have been stud... More »
 
While millions of prescriptions per year are written for drugs to calm the behavior of people with Alzheimer’s disease and other types of dementia, nonpharmacologic approaches may work better and carry far fewer risks, according to a report publish... More »
 

International Stroke Conference

NASHVILLE—Measuring optic nerve sheath size using noninvasive optic ultrasound may help clinicians identify patients at increased risk of death after acute stroke, according to research presented at the 2015 International Stroke Conference. The dia... More »
 
PET scans using radio-labeled flutemetamol are safe and confirm the presence or absence of neuritic β-amyloid levels “with high sensitivity and specificity,” according to research reported in the March issue of JAMA Neurology. “In vivo detecti... More »
 
Behaviors that enhance cognitive reserve or improve certain other psychosocial and health factors may offer a degree of protection from the cognitive decline associated with the APOE ε4 allele, according to research published in the March issue of J... More »
 
Patients with cluster headache show worse working memory, disturbance of mood, and poorer quality of life, compared with healthy controls, according to a report in the February issue of Headache. Furthermore, there are discernable differences between... More »
 

International Stroke Conference

NASHVILLE—Approximately one-third of patients with ischemic stroke whom neurologists consider too good to treat are unable to be discharged home, according to research presented at the 2015 International Stroke Conference. Mild or rapidly improving... More »
 
People at risk for dementia who were assigned to an intervention program that included healthy eating guidance, personalized exercise plans, and computer-based brain training scored better on cognitive tests after two years than a control group that ... More »
 

Headache Cooperative of the Pacific

SAN FRANCISCO—Although highly compelling data support the theory of glutamatergic involvement in migraine mechanisms, the evidence that glutamatergic modulation is clinically effective for patients with migraine remains elusive, according to an ove... More »
 

American Epilepsy Society

SEATTLE—Vagal nerve stimulation (VNS) decreases the number of disabling seizures and increases alertness in children with Dravet syndrome, according to a retrospective analysis presented at the 68th Annual Meeting of the American Epilepsy Society. ... More »
 

Biophysical Society

BALTIMORE—A common molecule may prolong cell survival in patients with serious neurologic conditions, according to research presented at the 59th Annual Meeting of the Biophysical Society. “The present findings could provide a new lead compound f... More »
 

Southern Clinical Neurological Society

NAPLES, FLORIDA—Psychiatric comorbidities, particularly depression, worsen the course of major neurologic conditions, according to research described at the 42nd Annual Meeting of the Southern Clinical Neurological Society. Among individuals with n... More »
 

Associated Professional Sleep Societies

MINNEAPOLIS—Narcolepsy entails a significant burden of illness and is associated with a substantial degree of medical comorbidity and health care burden, according to researchers reporting at the 28th Annual Meeting of the Associated Professional S... More »
 
A new formulation of extended-release hydrocodone has been approved by the FDA. According to the manufacturer, Zogenix, this new formulation has abuse-deterrent properties. Marketed as Zohydro ER, the new formulation contains extended-release hydroc... More »
 

Clinical Trials Conference

PHILADELPHIA—An amyloid PET scan with florbetapir detected which patients with mild cognitive impairment (MCI) had a high risk for further cognitive decline to Alzheimer’s disease in a large analysis of patients presented at the Clinical Trials C... More »
 
For patients with multiple sclerosis (MS), having no evidence of disease activity (NEDA) at two years has a positive predictive value of 78.3% for absence of progression at seven years, according to research published in the February issue of JAMA Ne... More »
 

International Stroke Conference

NASHVILLE—About 25% of patients with ischemic stroke who receive thrombolysis do so in the field before hospital transfer with the “drip-and-ship” paradigm, according to research presented at the 2015 International Stroke Conference. Although ... More »
 
Drinking more than two alcoholic beverages daily in middle age may raise a person’s stroke risk more than traditional factors such as high blood pressure and diabetes, according to new research published online ahead of print January 29 in Stroke. ... More »
 
Adolescents now are sleeping less per night than they did 20 years ago, according to research published online ahead of print February 16 in Pediatrics. The largest declines in nightly sleep time for all adolescents occurred between 1991 and 1995 and... More »
 
The use of electronic devices before bedtime and high screen usage during the day independently increase the likelihood of sleep deprivation among teenagers, according to a study published online ahead of print February 2 in BMJ Open. “While the f... More »
 

Headache Cooperative of the Pacific

At the eighth annual winter conference of HCOP, Dr. Cowan analyzes the American Headache Society's updated assessment of pharmacologic therapies for the acute treatment of migraine.... More »
 

Headache Cooperative of the Pacific

Dr. Tepper examines the evidence for various neuromodulation techniques for headache at the eighth annual winter conference of HCOP.... More »
 

Headache Cooperative of the Pacific

At the eighth annual winter conference of HCOP, Dr. Cutrer explains the current understanding of migraine aura.... More »
 

American Epilepsy Society

Dr. Joseph Sirven defines and offers treatment options for super-refractory status epilepticus.... More »
 

American Epilepsy Society

At the 2014 Annual Meeting of the AES, Dr. Hesdorffer lists risk factors for SUDEP.... More »
 
An investigator on the ESCAPE trial examines the current evidence for endovascular therapy in acute ischemic stroke.... More »
 
Dr. Cowan examines problems with the treatment of primary headache in the emergency department.... More »
 

Headache Cooperative of the Pacific

At the 2015 HCOP conference, Dr. Tepper describes products in development that target CGRP to treat migraine.... More »
 
Dr. Anne Berg details what the literature says and does not say about the treatment of pediatric epilepsy.... More »
 

American Neurological Association

Dr. Goadsby talks about CGRP and migraine at the 139th Annual Meeting of the American Neurological Association in Baltimore.... More »
 

MARCH 2015

This supplement is sponsored by Raptor Pharmaceuticals Inc.... More »
 

MARCH 2015

This advertorial is sponsored by Cadwell Laboratories, Inc.... More »